Voice as a predictive signal: protocol for a scoping review of AI in early childhood development

Mehrdad Amir-Behghadami1,2,3, Seifollah Heidarabadi1,2

  • 1Student Research Committee (SRC), Tabriz University of Medical Sciences, Tabriz, East Azerbaijan Province, Iran (the Islamic Republic of) seifollahheidarabady@gmail.com behghadami.m@gmail.com.

BMJ Open
|June 19, 2026
PubMed

Insights

Artificial intelligence (AI) and machine learning (ML) voice biomarkers can aid early detection of developmental delays in children aged 0-5 years. This review synthesizes evidence on AI-driven voice analysis for monitoring and managing early childhood development outcomes.

Area of Science:

  • Pediatric Health Informatics
  • Developmental Pediatrics
  • Artificial Intelligence in Healthcare

Background:

  • Current early childhood development (ECD) assessments face accessibility, cost, and invasiveness barriers.
  • Voice analysis offers a non-invasive digital biomarker for assessing children aged 0-5 years.
  • Artificial intelligence (AI) and machine learning (ML) can analyze vocal features for developmental insights.

Purpose of the Study:

  • To synthesize evidence on AI-driven voice biomarkers for early detection, monitoring, and management of ECD outcomes.
  • To explore the application of voice as a predictive signal in healthy, at-risk, or impaired children under five.
  • To inform the integration of AI in pediatric health informatics for equitable child development support.

Main Methods:

  • Scoping review protocol adhering to PRISMA-ScR and Arksey and O'Malley framework.
  • Population, Concept, Context (PCC) eligibility criteria for children aged 0-5 years, AI/ML voice biomarkers, and ECD outcomes.
  • Comprehensive literature searches across multiple databases (PubMed, Scopus, Web of Science, etc.) and grey literature, from January 2015 onwards.

Main Results:

  • Data extraction focused on clinical applications, recording protocols, acoustic features, AI models, demographics, and implementation factors.
  • Two independent reviewers screened titles, abstracts, and full texts.
  • Results will be presented narratively with supporting tables, charts, and figures.

Conclusions:

  • AI-driven voice biomarkers show promise for non-invasive ECD assessment.
  • Further research is needed to optimize AI models and clinical implementation for equitable child development.
  • This review will guide the integration of voice biomarkers in pediatric healthcare.
Abstract